MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease.

Athanasios Tampakis,Ekaterini Christina Tampaki,Afroditi Nonni,Michael Kontos,Gerasimos Tsourouflis,Alberto Posabella,Lana Fourie,Martin Bolli,Gregory Kouraklis,Markus von Flüe,Evangelos Felekouras,Nikolaos Nikiteas

Oncology（2021）

引用 0|浏览1

暂无评分

摘要

High MAP17 expression in patients with colorectal cancer is a significant risk factor for cancer-associated morbidity and mortality already in early stage disease.

查看译文

关键词

Cancer stem cells,Colorectal cancer,Disease recurrence,MAP17

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要